The top after-market NASDAQ gainers Wednesday were: Cleantech Solutions International, Loral Space & Communications, Ultra Clean Holdings, Charming Shoppes, Horizon Pharma and QuickLogic Corp. The top after-market NASDAQ losers were: Central European Distribution, Saba Software, Oncothyreon, Spectrum Pharmaceuticals, Brightcove Inc and Arena Pharmaceuticals.
Cleantech Solutions International, Inc. (CLNT) stock climbed 21.06 percent to $2.30 in post market session.
Loral Space & Communications, Inc. (LORL) stock surged 5.22 percent to $83.49 in aftermarket session. The company announced that its Board of Directors has declared a special dividend of $13.60 per share for an aggregate dividend of up to $421 million.
Ultra Clean Holdings, Inc. (UCTT) stock surged 5.19 percent to $8.11 in aftermarket session. The stock has a 52-week low of $3.77, a 52-week high of $12.54 and $178.05 million in market capitalization.
Charming Shoppes, Inc. (CHRS) stock surged 4.62 percent to $5.89 in post market session after gaining more than 4 percent in regular trading. The company is scheduled to participate at The Telsey Advisory Group's 4th Annual Spring Consumer Conference on Thursday, March 29, 2012 at 10:00 a.m. eastern time at The InterContinental Hotel New York Times Square.
Horizon Pharma, Inc. (HZNP) stock surged 4.52 percent to $3.70 in aftermarket session. The company announced that it filed a patent infringement lawsuit against Par Pharmaceutical Inc, seeking to block a generic version of its arthritis tablet Duexis, Reuters reported.
QuickLogic Corp. (QUIK) stock surged 3.6 percent to $2.59 in aftermarket session. The company stock declined nearly 2 percent in regular session.
Central European Distribution Corp. (CEDC) stock slumped 11.82 percent to $4.40 in post market session after plunging more than 7 percent in regular session.
Saba Software, Inc. (SABA) stock slumped 7 percent to $11.30 in aftermarket session. The company announced that it is delaying its third quarter fiscal year 2012 earnings release and investor conference call to allow the Company additional time to complete an internal review of the accounting treatment of certain international transactions.
Oncothyreon Inc. (ONTY) stock fell 4.6 percent to $4.15 in post market trading. The company announced its intention to offer shares of its common stock in an underwritten public offering.
Spectrum Pharmaceuticals, Inc. (SPPI) stock declined 3.71 percent to $12.46 in post market session. The stock has a 52-week low of $6.94, a 52-week high of $16.00 and $766.97 million in market capitalization.
Brightcove Inc. (BCOV) stock declined 2.53 percent to $23.14 in aftermarket session. The company stock climbed more than 6 percent in regular trading.
Arena Pharmaceuticals, Inc. (ARNA) stock declined 2.4 percent to $2.85 in post market session after slumping more than 10 percent in regular trading. The company stock was downgraded to “neutral” rating from “overweight” rating at Piper Jaffray.